Integrating genomics into clinical oncology: Ethical and social challenges from proponents of personalized medicine

Publication Type Journal Articles
Year of Publication 2014
Authors McGowan ML, Settersten RA, Juengst ET, Fishman JR
Journal Urologic Oncology: Seminars and Original Investigations
Volume 32
Issue 2
Pagination 187 – 192
Date Published 02/2014
ISSN 10781439
Abstract The use of molecular tools to individualize health care, predict appropriate therapies, and prevent adverse health outcomes has gained significant traction in the field of oncology under the banner of “personalized medicine” (PM). Enthusiasm for PM in oncology has been fueled by success stories of targeted treatments for a variety of cancers based on their molecular profiles. Though these are clear indications of optimism for PM, little is known about the ethical and social implications of personalized approaches in clinical oncology.
DOI 10.1016/j.urolonc.2013.10.009
Short Title Urologic Oncology: Seminars and Original Investigations